Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

September 3, 2021

Study Completion Date

May 31, 2026

Conditions
GBMGlioblastoma
Interventions
OTHER

Ketogenic Diet

A 4-month ketogenic diet will be supervised and monitored by the study investigators. Study dietitians will create personalized meal plans for each patient with the goal of achieving and maintaining metabolic ketosis.

RADIATION

Standard-of-care radiation

Patients will receive standard-of-care radiation. Radiation is not protocol directed.

DRUG

Standard-of-care Temozolomide

Patients will receive standard-of-care temozolomide. Temozolomide is not protocol directed.

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Jethro Hu

OTHER